中华老年心脑血管病杂志
中華老年心腦血管病雜誌
중화노년심뇌혈관병잡지
CHINESE JOURNAL OF GERIATRIC CARDIOVASCULAR AND CEREBROVASCULAR DISEASES
2014年
10期
1069-1072
,共4页
宋俊迎%李艳芳%蒋志丽%郭彦青
宋俊迎%李豔芳%蔣誌麗%郭彥青
송준영%리염방%장지려%곽언청
载脂蛋白E类%小鼠 ,基因敲除%血糖%胰岛素%受体 ,血管紧张素%肾上腺素能β激动剂
載脂蛋白E類%小鼠 ,基因敲除%血糖%胰島素%受體 ,血管緊張素%腎上腺素能β激動劑
재지단백E류%소서 ,기인고제%혈당%이도소%수체 ,혈관긴장소%신상선소능β격동제
apolipoproteins E%mice,knockout%blood glucose%insulin%receptors,angiotensin%adren-ergic beta-agonists
目的:探讨激动β3肾上腺素受体(β3-AR)对载脂蛋白E基因敲除(apoE-/-)小鼠血糖、胰岛素和胰腺血管紧张素Ⅱ受体(ATR)表达水平的影响。方法选用10周龄C57BL/6J小鼠10只为对照组(A 组),另选10周龄apo E-/-小鼠50只,高脂饮食至36周龄时随机分为高脂模型组(B组)、阿托伐他汀阳性药物对照组(C组)、β3-A R激动剂小剂量组(D组)、β3-A R激动剂大剂量组(E组)和β3-A R拮抗剂组(F组),干预12周。48周时检测小鼠血糖和胰岛素水平;采用实时定量PCR和Western blot检测各组小鼠AT1 R和AT2 R表达水平。结果与A组比较,B组血糖、胰岛素明显升高,AT1 R明显上调,AT2 R明显下调(P<0.01);与B组比较,D组、E组血糖、胰岛素明显降低,AT1 R明显下调,AT2 R明显上调(P<0.01)。结论长期应用β3-AR激动剂通过下调apoE-/-老年高脂小鼠胰腺AT1 R表达和上调AT2 R表达,β3-AR与AT1 R和AT2 R存在交互作用,且与改善糖代谢紊乱有关。
目的:探討激動β3腎上腺素受體(β3-AR)對載脂蛋白E基因敲除(apoE-/-)小鼠血糖、胰島素和胰腺血管緊張素Ⅱ受體(ATR)錶達水平的影響。方法選用10週齡C57BL/6J小鼠10隻為對照組(A 組),另選10週齡apo E-/-小鼠50隻,高脂飲食至36週齡時隨機分為高脂模型組(B組)、阿託伐他汀暘性藥物對照組(C組)、β3-A R激動劑小劑量組(D組)、β3-A R激動劑大劑量組(E組)和β3-A R拮抗劑組(F組),榦預12週。48週時檢測小鼠血糖和胰島素水平;採用實時定量PCR和Western blot檢測各組小鼠AT1 R和AT2 R錶達水平。結果與A組比較,B組血糖、胰島素明顯升高,AT1 R明顯上調,AT2 R明顯下調(P<0.01);與B組比較,D組、E組血糖、胰島素明顯降低,AT1 R明顯下調,AT2 R明顯上調(P<0.01)。結論長期應用β3-AR激動劑通過下調apoE-/-老年高脂小鼠胰腺AT1 R錶達和上調AT2 R錶達,β3-AR與AT1 R和AT2 R存在交互作用,且與改善糖代謝紊亂有關。
목적:탐토격동β3신상선소수체(β3-AR)대재지단백E기인고제(apoE-/-)소서혈당、이도소화이선혈관긴장소Ⅱ수체(ATR)표체수평적영향。방법선용10주령C57BL/6J소서10지위대조조(A 조),령선10주령apo E-/-소서50지,고지음식지36주령시수궤분위고지모형조(B조)、아탁벌타정양성약물대조조(C조)、β3-A R격동제소제량조(D조)、β3-A R격동제대제량조(E조)화β3-A R길항제조(F조),간예12주。48주시검측소서혈당화이도소수평;채용실시정량PCR화Western blot검측각조소서AT1 R화AT2 R표체수평。결과여A조비교,B조혈당、이도소명현승고,AT1 R명현상조,AT2 R명현하조(P<0.01);여B조비교,D조、E조혈당、이도소명현강저,AT1 R명현하조,AT2 R명현상조(P<0.01)。결론장기응용β3-AR격동제통과하조apoE-/-노년고지소서이선AT1 R표체화상조AT2 R표체,β3-AR여AT1 R화AT2 R존재교호작용,차여개선당대사문란유관。
Objective To study the effect ofβ3 adrenoceptor (β3-AR)activation on serum blood glu-cose and insulin level and expression of pancreatic angiotensin receptor (ATR) in apoE/mice . Methods Ten wild-type C57BL/6J mice at the age of 10 weeks served as a normal control group (group A)and 50 apoE/mice at the age of 10 weeks fed with high fat diet to 36 weeks old were randomly divided into hyperlipidaemia model group (group B ) ,atorvastatin treatment group (group C) ,low β3-AR agonist dose group (group D) ,high β3-AR agonist dose group (group E) andβ3-AR antagonist group (group F) ,10 in each group .The mice were treated withβ3-AR ago-nist and antagonist for 12 weeks .Serum blood glucose and insulin levels in 48 weeks old mice were measured using an automatic biochemical detector .Expression of AT1 R and AT2 R in pancre-atic tissues of mice was detected by RT-PCR and Western blot ,respectively .Results The serum blood glucose and insulin levels were significantly higher ,the expression level of AT1 R was sig-nificantly higher while that of AT2R was significantly lower in group B than in group A (P<0.01) .The serum blood glucose and insulin levels were significantly lower ,the expression level of AT1 R was significantly lower while that of AT2 R was significantly higher in groups D and E than in group B ( P<0 .01) .Conclusion Long-term use of β3-AR agonist can improve blood glucose metabolism in apoE/mice by down-regulating the AT1 R expression and up-regulating the AT2 R expression ,indicating that β3-AR interacts with AT1 R and AT2 R .